WallStreetZenWallStreetZen

NYSE: FNF
Fidelity National Financial Inc Stock Forecast, Predictions & Price Target

Analyst price target for FNF

Based on 4 analysts offering 12 month price targets for Fidelity National Financial Inc.
Min Forecast
$51.00-1.85%
Avg Forecast
$54.75+5.37%
Max Forecast
$60.00+15.47%

Should I buy or sell FNF stock?

Based on 4 analysts offering ratings for Fidelity National Financial Inc.
Buy
Strong Buy
2 analysts 50%
Buy
0 analysts 0%
Hold
2 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their FNF stock forecasts and price targets.

FNF stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-21
lockedlocked$00.00+00.00%2024-02-23
lockedlocked$00.00+00.00%2024-02-23Find Out Why
lockedlocked$00.00+00.00%2023-11-14

1 of 1

Forecast return on equity

Is FNF forecast to generate an efficient return?

Forecast return on assets

Is FNF forecast to generate an efficient return on assets?

FNF revenue forecast

What is FNF's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$12.7B+7.73%
Avg 2 year Forecast
$14.2B+20.83%
FNF's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FNF revenue growth forecast

How is FNF forecast to perform vs Insurance - Specialty companies and vs the US market?
Company
7.73%
Industry
12.62%
Market
13.87%
FNF's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FNF's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FNF vs Specialty Insurance Stocks

TickerPricePrice TargetUp/downsideConsensus
FNF$51.96$54.75+5.37%Buy
RYAN$55.72$51.40-7.75%Hold
AIZ$187.41$196.00+4.58%Strong Buy
ESNT$59.04$57.33-2.89%Buy
FAF$59.83$64.67+8.08%Buy

Fidelity National Financial Stock Forecast FAQ

Is Fidelity National Financial Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: FNF) stock is to Buy FNF stock.

Out of 4 analysts, 2 (50%) are recommending FNF as a Strong Buy, 0 (0%) are recommending FNF as a Buy, 2 (50%) are recommending FNF as a Hold, 0 (0%) are recommending FNF as a Sell, and 0 (0%) are recommending FNF as a Strong Sell.

If you're new to stock investing, here's how to buy Fidelity National Financial stock.

What is FNF's revenue growth forecast for 2024-2025?

(NYSE: FNF) Fidelity National Financial's forecast annual revenue growth rate of 7.73% is not forecast to beat the US Insurance - Specialty industry's average forecast revenue growth rate of 12.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.87%.

Fidelity National Financial's revenue in 2024 is $11,752,000,000.On average, 2 Wall Street analysts forecast FNF's revenue for 2024 to be $3,458,926,353,335, with the lowest FNF revenue forecast at $3,155,535,918,150, and the highest FNF revenue forecast at $3,762,316,788,520.

In 2025, FNF is forecast to generate $3,879,418,589,839 in revenue, with the lowest revenue forecast at $3,468,630,650,808 and the highest revenue forecast at $4,290,206,528,871.

What is FNF's forecast return on assets (ROA) for 2024-2025?

(NYSE: FNF) forecast ROA is N/A, which is lower than the forecast US Insurance - Specialty industry average of -0.04%.

What is FNF's Price Target?

According to 4 Wall Street analysts that have issued a 1 year FNF price target, the average FNF price target is $54.75, with the highest FNF stock price forecast at $60.00 and the lowest FNF stock price forecast at $51.00.

On average, Wall Street analysts predict that Fidelity National Financial's share price could reach $54.75 by Mar 21, 2025. The average Fidelity National Financial stock price prediction forecasts a potential upside of 5.37% from the current FNF share price of $51.96.

What is FNF's forecast return on equity (ROE) for 2024-2025?

(NYSE: FNF) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.